Kim Smyth is a strategic leader with deep expertise in digital and data transformation with a particular focus in health and life sciences.  She brings a track record of advancing evidence-based innovation in highly regulated environments both within Australia and internationally.

Previously she has served as GM Investment for ANDHealth, a non-profit organisation supporting growth of the digital health sector in Australia, where she facilitated advisory meetings to select participants and projects for $33m of funding across three incubator programs.  Her career spans senior innovation and commercialisation roles in the pharmaceutical industry in Australia and the US, including leadership roles in major global transformation programs.  She has extensive management consulting experience in advising executive teams and boards on corporate strategy, with a focus on emerging technologies and growth.

She is participating as a Board Observer with ARIIA through the WILD for STEM  BoardX program, which prepares women in STEM for governance roles.